NDP001: Extended lymphadenectomy improves the prognosis of the patients with muscle invasive bladder cancer: analysis from the nationwide cancer registry database

NDP002: Patients with pathological t3 prostate cancer treated with robot-assisted radical prostatectomy - a single institue experience

NDP003: Trend of global quality of life in localized or metastatic prostate cancer patients after treatment

NDP004: Analysis of detrusor muscle sampling during transurethral resection of bladder tumor in non-muscle invasive bladder cancer

NDP005: Semi-rigid ureteroscopy with thullium laser for the treatment of ureter urothelial carcinoma: experience of mackay memorial hospital.

NDP006: Complementary traditional chinese medicine therapy improves survival in patients with metastatic prostate cancer

NDP007: Upper urinary tract transitional cancer-the experiences in recent 5 years and literature review

NDP008: The clinical presentation of renal cell carcinoma with simultaneous different histologic type, a 15–year database analysis in Taipei Veterans General Hospital

NDP009: The safety and efficacy of low dose bcg intravesical instillation for the treatment of uremic or kidney transplant patients with recurrent urothelial carcinoma of the bladder

NDP010: The serum microrna in prostate cancer patients as a biomarker for early detection

NDP011: The molecular mechanism of the inhibitory effect on prostate cancer cell growth through the direct action of estrogen on estrogen receptor

NDP012: Evaluation of fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis and staging of upper urinary tract urothelial carcinoma

NDP013: The prognostic impact of multifocality for upper tract urothelial carcinoma patients after radical nephroureterectomy

NDP014: Clinical features of patients with non-malignant upper tract lesions mimicking urothelial cancer

NDP015: Clinical and therapeutic implications of neuroendocrine prostate cancer: a long winding road to cure